Target intelligence / Profile preview

Immune system cells via cell–cell contact and secreted factors

Molecular classification
Other
01

Overview

The term Immune system cells via cell–cell contact and secreted factors refers to the integrated network of biological processes that coordinate the body's defense mechanisms, rather than a single molecular target. This system relies on two primary modes of communication: juxtacrine signaling, which involves direct physical contact between surface receptors and ligands (such as the T-cell receptor interacting with MHC molecules), and paracrine/endocrine signaling via secreted factors like cytokines, chemokines, and interferons (Alberts B, et al., Molecular Biology of the Cell, 6th ed., 2014). In a pharmacological context, this entry typically describes the broad mechanism of immunomodulators, which are drugs designed to either stimulate or suppress these interactions to treat disease (National Cancer Institute, NCI Thesaurus, 'Immunomodulator'). For example, checkpoint inhibitors block inhibitory cell-cell contacts to enhance anti-tumor immunity, while biologics like TNF-alpha inhibitors neutralize secreted factors to reduce chronic inflammation (Janeway CA Jr, et al., Immunobiology, 5th ed., 2001). Because this term encompasses a vast array of distinct proteins, cell types, and pathways, it is classified as a therapeutic category or biological system rather than a specific druggable receptor or enzyme.

Other names
Immune systemImmunomodulationCell-mediated and humoral immunityImmune cell communicationParacrine and juxtacrine signaling
02

Mechanism of action

Modulation of the immune response through the alteration of physical cell-to-cell interactions or the signaling of secreted cytokines and chemokines.

03

Biological functions

Immune responseSignal transductionCell-cell communicationInflammationHomeostasis
04

Disease associations

CancerInflammationAutoimmune diseaseInfectionGraft-versus-host disease
05

Safety considerations

Cytokine release syndrome (CRS)Immune-related adverse events (irAEs)Opportunistic infectionsAnaphylaxis
06

Interacting drugs

Cyclosporine

4 more in the full profile.

07

Biomarkers

Cytokine profilesC-reactive protein (CRP)Immune cell subset counts (CD4+/CD8+)Soluble IL-2 receptor

Beyond the preview

Go deeper on Immune system cells via cell–cell contact and secreted factors.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Immune system cells via cell–cell contact and secreted factors.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call